Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Quantum Genomics Will Present Top-line Results From its QUORUM Study of Firibastat in Heart .
Quantum GenomicsApril 21, 2021 GMT
PARIS, April 21, 2021 (GLOBE NEWSWIRE) Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, will present top-line results from its QUORUM study of firibastat in heart failure post myocardial infarction at the European Society of Cardiology (ESC) meeting in August 2021. These results will also be published in a peer-review journal.
Germany
New-york
United-states
Paris
France-general
France
Hungary
United-kingdom
Poland
Spain
French
Gilles-montalescot